Latest posts tagged with #BioStock on Bluesky
Adults in Europe living with obesity now have a higher dosage option for weight management. Novo Nordisk secured European Commission approval for a 7.2 mg once-weekly maintenance dose of Wegovy. #NovoNordisk #BioStock
Devyser Diagnostics expands its genetic testing portfolio by acquiring Cybergene. The SEK 12.2 million deal, paid in shares, adds products for aneuploidy and male infertility to the company lineup. #BioStock #diagnostics
US market access remains a rigorous process. Gradientech reports that the FDA has requested supplementary information, requiring the company to provide additional data for its regulatory filing. #MedTech #BioStock
Antibiotic resistance is limiting treatment options for tuberculosis globally. Hamlet BioPharma has signed an agreement with ImmunoForge to develop administration technology for the peptide drug NZX targeting pulmonary TB. #BioStock #Tuberculosis
AstraZeneca faces a regulatory hurdle for its lupus treatment expansion. The FDA issued a Complete Response Letter regarding the application for Saphnelo subcutaneous administration in SLE, following the Phase III TULIP-SC trial results. #BioStock #FDA
The first immunotherapy-based perioperative therapy for gastric cancer is nearing EU approval. CHMP recommended AstraZeneca's Imfinzi based on Phase III data showing a 29% reduction in the risk of progression, recurrence, or death. #AstraZeneca #BioStock
AstraZeneca is solidifying its long-term strategy in Asia with a massive financial pledge. The company announced a USD 15 billion investment in China through 2030 to support R&D and manufacturing operations. #AstraZeneca #BioStock
